MARKET

CASI

CASI

Casi Pharmaceuticals Inc
NASDAQ
0.9247
-0.0253
-2.66%
After Hours: 0.9247 0 0.00% 16:10 02/06 EST
OPEN
0.9237
PREV CLOSE
0.9500
HIGH
0.9500
LOW
0.9050
VOLUME
17.36K
TURNOVER
--
52 WEEK HIGH
3.090
52 WEEK LOW
0.7500
MARKET CAP
19.00M
P/E (TTM)
-0.3098
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at CASI last week (0126-0130)?
Weekly Report · 5d ago
Weekly Report: what happened at CASI last week (0119-0123)?
Weekly Report · 01/26 10:32
CASI Pharmaceuticals Fails To Renew FOLOTYN Import License In China, Halting Sales
Benzinga · 01/22 14:07
Weekly Report: what happened at CASI last week (0112-0116)?
Weekly Report · 01/19 10:39
Casi Pharmaceuticals announces NMPA approval of CTA for Phase 1/2 CID-103 study
TipRanks · 01/15 14:15
CASI Pharmaceuticals Gets China National Medical Products Administration's Approval To Start Phase1/2 Clinical Study For CID-103 In Adults With Chronic Active Renal Allograft Antibody-Mediated Rejection
Benzinga · 01/15 14:05
CASI Pharmaceuticals Receives China NMPA Approval for Phase 1/2 Clinical Trial of CID-103 in Renal Allograft AMR
Reuters · 01/15 14:00
12 Health Care Stocks Moving In Wednesday's After-Market Session
Benzinga · 01/14 21:06
More
About CASI
CASI Pharmaceuticals Inc is a holding company principally engaged in developing and commercializing innovative therapeutics and pharmaceutical products. The Company’s main business is engaged in acquiring, developing and commercializing products that augment its hematology oncology, autoimmune and organ transplant rejection therapeutic area focus as well as other unmet medical need. The Company’s main products include EVOMELA (Melphalan for Injection), FOLOTYN (Pralatrexate), CNCT19, BI-1206, CB-5339, CID-103, Thiotepa and others. The Company mainly conducts its business in the domestic market.

Webull offers CASI Pharmaceuticals Inc stock information, including NASDAQ: CASI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CASI stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading CASI stock methods without spending real money on the virtual paper trading platform.